Examples of using Are not satisfactorily controlled in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
In patients who are not satisfactorily controlled on metformin(a diabetes medicine) used on its own;
Vildagliptin can be used with metformin in type 2 diabetes patients who are not satisfactorily controlled on metformin alone.
Avandamet is used in patients who are not satisfactorily controlled on metformin(an antidiabetes medicine) used on its own and at the maximum possible dose‘dual therapy.
Actos is approved for use with a sulphonylurea in type 2 diabetes patients who are not satisfactorily controlled on metformin alone.
In patients who are not satisfactorily controlled with pioglitazone alone, and who cannot be treated with metformin(another diabetes medicine); together with metformin, in patients who are not satisfactorily controlled with a combination of pioglitazone and metformin.
Repaglinide is also indicated in combination with metformin in type 2 diabetes patients who are not satisfactorily controlled on metformin alone.
Glidipion can also be used in combination with metformin in patients who are not satisfactorily controlled on metformin alone, or with a sulphonylurea(another type of antidiabetes medicine) when metformin is not suitable‘dual therapy.
Repaglinide is also indicated in combination with metformin in adults with type 2 diabetes mellitus who are not satisfactorily controlled on metformin alone.
Paglitaz can also be used in combination with metformin in patients who are not satisfactorily controlled on metformin alone, or with a sulphonylurea(another type of antidiabetes medicine)
in type 2 diabetes patients whose blood glucose levels are not satisfactorily controlled on metformin alone.
Invokana can be used on its own in patients whose blood glucose levels are not satisfactorily controlled on diet and exercise alone
can be used with metformin in type 2 diabetes patients who are not satisfactorily controlled on metformin alone.
levels are not satisfactorily controlled on diet and exercise alone
to be used with metformin in type 2 diabetes patients who are not satisfactorily controlled on metformin alone.
a sulphonylurea in patients who are not satisfactorily controlled despite treatment with two medicines by mouth; together with insulin in patients who are not satisfactorily controlled with insulin alone and cannot take metformin.
Reproduction is authorised provided the source is acknowledged. in combination with insulin, with or without metformin, in patients who are not satisfactorily controlled on a stable dose of insulin.
In combination with metformin in patients who are not satisfactorily controlled on metformin alone, or with a sulphonylurea(another type of diabetes medicine) when metformin is not suitable in patients who are not satisfactorily controlled on a sulphonylurea alone;
with both metformin and a sulphonylurea in patients who are not satisfactorily controlled despite dual therapy by mouth‘triple therapy.
On its own, in patients who are not satisfactorily controlled on diet and exercise and in whom metformin(a diabetes medicine) is not suitable; in combination with metformin or a PPAR-gamma agonist(a type of diabetes medicine) such as a thiazolidinedione, in patients who are not satisfactorily controlled on metformin or the PPAR- gamma agonist used on its own;
Glidipion can also be used together with insulin in patients who are not satisfactorily controlled with insulin alone and cannot take metformin.
insulin(other types of antidiabetes medicine) in patients who are not satisfactorily controlled on this medicine and metformin.
It can be added to metformin in patients(particularly those who are overweight) who are not satisfactorily controlled on metformin used on its own
type of antidiabetes medicine) in patients who are not satisfactorily controlled with a sulphonylurea used on its own and in whom metformin is not suitable; in combination with both metformin and a sulphonylurea or a PPAR-gamma agonist, in patients who are not satisfactorily controlled on the two medicines;
type of antidiabetes medicine) in patients who are not satisfactorily controlled on metformin and a sulphonylurea at their maximum possible doses‘triple therapy.
when used alone in patients whose blood glucose levels were not satisfactorily controlled on diet and exercise alone.
The third included 641 patients who were not satisfactorily controlled on a stable dose of insulin,
The first included 1,091 patients who were not satisfactorily controlled on diet and exercise alone